Table 2.

Measurements of parameters for determining efficacy of ExT

Parameters	n	WKY‐Sed	WKY‐ExT	SHR‐Sed	SHR‐ExT
Body weight (BW, g)	15	311 ± 8	281 ± 5*	301 ± 5	277 ± 4†
SMW (mg)	15	106 ± 4	130 ± 3*	101 ± 4	135 ± 4†
SMW/BW (mg/g)	15	0.34 ± 0.01	0.46 ± 0.01*	0.34 ± 0.01	0.49 ± 0.02†
Content of CS in SMW (pg/mg)	5	653 ± 35	788 ± 38*	695 ± 15	765 ± 32†
MAP (mmHg)	5	120 ± 2	115 ± 7	171 ± 7*	145 ± 4*, †
HR (beats/min)	5	390 ± 14	342 ± 9*	443 ± 6*	382 ± 5†
Baseline RSNA (% of Max)	5	30.2 ± 3.0	27.1 ± 2.6	53.7 ± 4.5*	41.2 ± 3.6*, †

n, number of animals; MAP, mean arterial pressure; SMW, Soleus muscle wet weight; CS, citrate synthase; MAP, mean arterial pressure; RSNA, renal sympathetic nerve activity; WKY‐Sed, Wistar‐Kyoto‐sedentary; SHR‐Sed, spontaneously hypertensive rat‐sedentary; WKY‐ExT, Wistar‐Kyoto‐exercise training; SHR‐ExT, spontaneously hypertensive rat‐ exercise training. Data are mean ± SE. Values for MAP, HR, and inte‐RSNA were obtained in anaesthetized rats. MAP was measured by catheterizing femoral artery. *P < 0.05 versus WKY‐Sed. †P < 0.05 versus SHR‐Sed.